sunitinib krka 12,5 mg harde caps.
krka d.d. novo mesto d.d. - sunitinibmalaat 16,71 mg - eq. sunitinib 12,5 mg - capsule, hard - 12,5 mg - sunitinibmalaat 16.71 mg - sunitinib
sunitinib krka 25 mg harde caps.
krka d.d. novo mesto d.d. - sunitinibmalaat 33,41 mg - eq. sunitinib 25 mg - capsule, hard - 25 mg - sunitinibmalaat 33.41 mg - sunitinib
sunitinib krka 50 mg harde caps.
krka d.d. novo mesto d.d. - sunitinibmalaat 66,83 mg - eq. sunitinib 50 mg - capsule, hard - 50 mg - sunitinibmalaat 66.83 mg - sunitinib
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische middelen - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib holsten 12,5 mg harde capsules
holsten pharma gmbh hanstrasse 31-35 60528 frankfurt am main (duitsland) - sunitinibmalaat samenstelling overeenkomend met ; sunitinib - capsule, hard - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; magnesiumstearaat (e 470b) ; povidon k 30 (e 1201) ; propyleenglycol (e 1520) ; schellak (e 904) ; titaandioxide (e 171) ; witte inkt
sunitinib holsten 25 mg harde capsules
holsten pharma gmbh hanstrasse 31-35 60528 frankfurt am main (duitsland) - sunitinibmalaat samenstelling overeenkomend met ; sunitinib - capsule, hard - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; magnesiumstearaat (e 470b) ; povidon k 30 (e 1201) ; propyleenglycol (e 1520) ; schellak (e 904) ; titaandioxide (e 171) ; witte inkt
sunitinib holsten 50 mg harde capsules
holsten pharma gmbh hanstrasse 31-35 60528 frankfurt am main (duitsland) - sunitinibmalaat samenstelling overeenkomend met ; sunitinib - capsule, hard - ammonia (e 527) ; cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; magnesiumstearaat (e 470b) ; povidon k 30 (e 1201) ; propyleenglycol (e 1520) ; schellak (e 904) ; titaandioxide (e 171) ; zwarte inkt
sunitinib teva 12.5 mg harde caps.
teva b.v. - sunitinib 12,5 mg - capsule, hard - 12,5 mg - sunitinib 12.5 mg - sunitinib
sunitinib teva 25 mg harde caps.
teva b.v. - sunitinib 25 mg - capsule, hard - 25 mg - sunitinib 25 mg - sunitinib
sunitinib teva 37.5 mg harde caps.
teva b.v. - sunitinib 37,5 mg - capsule, hard - 37,5 mg - sunitinib 37.5 mg - sunitinib